A review of neurological sequelae and cognitive deficits associated with antiphospholipid antibodies

Journal of Stroke and Cerebrovascular Diseases

Volumn 6, Issue 2, 1996, Pages 61-66

  Jacobson, Mark W ^a   Abraham, Elizabeth ^b   Tietjen, Gretchen E ^c  

^a WAYNE STATE UNIVERSITY   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c HENRY FORD HOSPITAL   (United States)

Author keywords

Antiphospholipid antibodies; Cognitive deficits; Neurobehavioral disorder; Neurological deficit; Neuropsychology

Indexed keywords

EID: 0009658433     PISSN: 10523057     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1052-3057(96)80004-8     Document Type: Review

References (45)

1. Levine S.R., and Welch K. The spectrum of neurological disease associated with antiphospholipid antibodies: lupus anticoagulants and anticardiolipin antibodies. Arch Neurol 543 (1987) 876-883
2. Tietjen G.E. Migraine and antiphospholipid antibodies. Cephalalgia 12 (1992) 70-74
3. Harris E.N., Gharavi A.E., and Hughes G.R.V. Antiphospholipid antibodies. Clin Rheum Dis 11 (1985) 591-609
4. Omdal R., and Roalso S. Chorea gravidarum and chorea associated with oral contraceptives-diseases due to antiphospholipid antibodies?. Acta Neurol Scand 86 (1992) 219-220
5. Asherson R.A., Mercey D., and Phillips G. Recurrent stroke, multi-infarct dementia in systemic lupus erythematosus associated with antiphospholipid antibodies. Ann Rheum Dis 46 (1987) 605-607
6. Harris E.N., Philk M., and Asherson R.A. Antiphospholipid antibodies-autoantibodies with a difference. Annu Rev Med 39 (1988) 261-266
7. Asherson R.A., Mayou S.L., and Merry P. The spectrum of livedo reticularis and anticardiolipin antibodies. Br J Dermtol 120 (1989) 115-120
8. Asherson R.A. "Primary" anti-phospholipid syndrome. In: Harris E.N., Exner T., Hughes G.R.V., and Asherson R.A. (Eds). Phospholipid-binding antibodies (1991), CRC Press, Boca Raton, FL 373-423
9. Love P.E., and Santoro S.A. Antiphospholipid antibodies: anticardiolipin and the lupus anticoagulant in systemic lupus erythematosus (SLE) and non-SLE Disorders. Ann Intern Med 112 (1990) 682-698
10. Lockshin M.D. Antiphospholipid antibody syndrome. JAMA 268 (1992) 1451-1453
11. Cohen A.J., Phillips T.M., and Kessler C.M. Circulating coagulation inhibitors in the acquired immunodeficiency syndrome. Ann Intern Med 104 (1986) 175-180
12. Chengappa K.N.R., Carpenter A.B., and Keshavan M.S. Elevated IgG and IgM anticardiolipin antibodies in a subgroup of medicated and unmedicated schizophrenic patients. Biol Psychiatry 30 (1991) 731-735
13. Toren P., Toren A., Weizman A., et al. Tourette's disorder: is there an association with the antiphospholipid syndrome?. Biol Psychiatry 35 (1994) 495-498
14. Maes M., Meltzer H., Jacobs J., et al. Autoimmunity in depression: increased antiphospholipid autoantibodies. Acta Psychiatr Scand 87 (1993) 160-166
15. Canoso R.T., and de Oliveira R. Chlorpromazine-induced anti-cardiolipin an T body and lupus anticoagulant: absence of thrombosis. Am J Hematol 27 (1988) 272-275
16. Levine S.R., and Welch K. Antiphospholipid antibodies. Ann Neurol 26 (1989) 386-389
17. Hughes G.R.V. The antiphospholipid syndrome: ten years on. Lancet 342 (1993) 341-344
18. Matthy F., Walshe K., Mackie I.J., and Machin S.J. Familial occurrence of the antiphospholipid syndrome. J Clin Pathol 42 (1989) 495-497
19. Triplett D.A., Brandt J.T., and Maas R.L. The laboratory heterogeneity of lupus anticoagulants. Arch Pathol Lab Med 109 (1985) 946-951
20. Trimble M., Bell D.A., Brien W., et al. The antiphospholipid syndrome: prevalence among patients with stroke and transient ischemic attacks. Am J Med 88 (1990) 593-597
21. Gharavi A.E., Harris E.N., Asherson R.A., and Hughes G.R.V. Anticardiolipin antibodies: isotype distribution and phospholipid specificity. Ann Rheum Dis 46 (1986) 1-6
22. Carreras L.O., and Vernylen J.G. Lupus anticoagulant and thrombosis-possible role of inhibition of prostacyclin formation. Thromb Haemost 48 (1982) 38-40
23. Nencini P., Baruffi M.C., Abbate R., Massai G., Amaducci L., and Inzitari D. Lupus anticoagulant and anticardiolipin antibodies in young adults with cerebral ischemia. Stroke 23 (1992) 189-193
24. Montalban J., Codina A., Ordi J., Vilardell M., Khamashta M., and Hughes G.R.V. Antiphospholipid antibodies in cerebral ischemia. Stroke 22 (1991) 750-753
25. Czlonkowska A., Meurer M.L., Palasik W., Baranska-Gierusczcak M., Mendel T., and Wierzchowska E. Anticardiolipin antibodies, a disease marker for ischemic cerebrovascular events in a younger population. Acta Neurol Scand 86 (1992) 304-307
26. Digre K.B., Durcan F.J., Branch D.W., Jacobson D.M., Varner M.W., and Baringer J.R. Amaurosis fugax associated with antiphospholipid antibodies. Ann Neurol 25 (1989) 228-232
27. Rosove M., and Brewer P.M.C. Antiphospholipid thrombosis: clinical course after the first thrombotic event in 70 patients. Ann Intern Med 117 (1992) 303-308
28. Coull B.M., and Goodnight S.H. Antiphospholipid antibodies, prethrombotic states, and stroke. Stroke 21 (1990) 1370-1374
29. Khamashta M.A., Harris E.N., Gharavi A.E., et al. Immune mediated mechanisms for thrombosis: antiphospholipid antibody binding to platelet membranes. Ann Rheum Dis 47 (1988) 849-854
30. The Antiphospholipid Antibodies in Stroke Study Group. Clinical and laboratory findings in patients with antiphospholipid antibodies and cerebral ischemia. Stroke 21 (1990) 1268-1273
31. Freyssinet J.M., and Cazenave J.P. Lupus-like anticoagulants, modulation of the protein C pathway and thrombosis. Thromb Haemost 61 (1989) 175-177
32. Hess D.C., Krauss J., Adams R.J., Nichols F.T., Ahang D., and Rountree H.A. Anticardiolipin antibodies: a study of frequency in TIA and stroke. Neurology 41 (1990) 525-528
33. Provenzale J.M., Heinz E.R., Ortel T.L., Macik B.G., Charles L.A., and Alberts M.J. Antiphospholipid antibodies in patients without systemic lupus erythematosus: neuroradiologic findings. Radiology 192 (1994) 531-537
34. Briley D.P., Coull B.M., and Goodnight S.H. Neurological disease associated with antiphospholipid antibodies. Ann Neurol 25 (1989) 221-227
35. Harris E.N., Asherson R.A., and Hughes G.R.V. Antiphospholipid antibodies-autoantibodies with a difference. Annu Rev Med 39 (1988) 261-271
36. Coull B.M., Bourdette D., Goodnight S.H., Briley D.P., and Hart R. Multiple cerebral infarctions and dementia associated with anticardiolipin antibodies. Stroke 18 (1987) 1107-1112
37. Kurita A., Hasunuma T., Mochio S., Shimada T., Yukihide I., and Kurahasi T. A young case with multi-infarct dementia associated with lupus anticoagulant. Intern Med 33 (1994) 373-376
38. Kurtz G., and Muller N. The antiphospholipid syndrome and psychosis. Am J Psychiatry 151 (1994) 1841-1842
39. Gorman D.G., and Cummings J.L. Neurobehavioral presentations of the antiphospholipid antibody syndrome. J Neuropsych Clin Neurosci 5 (1993) 37-42
40. Maeshima E., Yoichi Y., Susumu Y.L., and Nomoto H. Higher cortical dysfunction, antiphospholipid antibodies and neuroradiological examinations in systemic lupus erythematosus. Intern Med 31 (1992) 1169-1174
41. Keenan P.A., Jacobson M.W., Soleymani R.M., and Newcomer J.W. Commonly used therapeutic doses of glucocorticoids impair explicit memory. Ann NY Acad Sci 761 (1995) 400-402
42. Schmidt R., Auer-Grumbach P., Fazekas F., Offenbacher H., and Kapeller P. Anticardiolipin antibodies in normal subjects: neuropsychological correlates and MRI findings. Stroke 26 (1995) 749-754
43. Hindfelt B., and Nilsson O. The prognosis of ischemic stroke in young adults. Acta Neurol Scand 55 (1977) 123-130
44. Denburg S., Carbotte R., Ginsberg J., McComas A., and Denburg J. Antiphospholipid antibodies and cognitive function in systemic lupus. Abstr Soc Neurosci 21 (1995) 221
45. Aharon-Peretz J., Brenner B., Amyel-Zvi E., and Metz L. Neurocognitive dysfunction in the antiphospholipid antibody syndrome (APS). Neuropsychiat Neuropsychol & Behav Neurol 9 (1996) 123-126